» Articles » PMID: 35303621

Discovery of New ERRγ Agonists Regulating Dopaminergic Neuronal Phenotype in SH-SY5Y Cells

Overview
Journal Bioorg Chem
Publisher Elsevier
Specialties Biochemistry
Chemistry
Date 2022 Mar 18
PMID 35303621
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of small molecules that regulate specific neuronal phenotypes is important for the development of new therapeutic candidates for neurological diseases. Estrogen-related receptor γ (ERRγ), an orphan nuclear receptor widely expressed in the central nervous system (CNS), is closely related to the regulation of neuronal metabolism and differentiation. We previously reported that upregulation of ERRγ could enhance dopaminergic neuronal phenotypes in the neuroblastoma cell line, SH-SY5Y. In this study, we designed and synthesized a series of new ERRγ agonists using the X-ray crystal structure of the GSK4716-bound ERRγ complex and known synthetic ligands. Our new ERRγ agonists exhibited increased transcriptional activities of ERRγ. In addition, our molecular docking results supported the experimental findings for ERRγ agonistic activity of the potent analogue, 5d. Importantly, 5d not only enhanced the expression of dopaminergic neuronal-specific molecules, TH and DAT but also activated the relevant signaling events, such as the CREB-mediated signaling pathway. The results of the present study may provide useful clues for the development of novel ERRγ agonists for neurological diseases related to the dopaminergic nervous system.

Citing Articles

Research Progress in Estrogen-related Receptor Gamma (ERRγ) Agonists and Inverse Agonists.

Zheng Y, Du Y, Zhang H, Lv H, Yan Z, Dong N Curr Med Chem. 2023; 31(24):3653-3667.

PMID: 37202889 DOI: 10.2174/0929867330666230518140631.